Global Anti-Infective Agents Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Market is witnessing the rise of novel antimicrobial peptides and CRISPR-based therapeutics for infectious disease control

• Anti-infective agents are chemicals or drugs that fight infections caused by bacteria, viruses, fungus, or parasites. They kill or block the growth and reproduction of infectious agents (antibiotics, antivirals, antifungals). These medicines are critical in the treatment of a variety of infectious diseases in both people and animals.
• The rising prevalence of infectious diseases globally is driving the demand for anti-infective drugs. Population expansion, urbanization, and worldwide travel all contribute to the spread of diseases, increasing the need for better therapies. This increase in infectious diseases encourages research & development activities, releasing new and improved anti-infective medications, boosting the market's expansion even further.
• Another key market driver is the increasing number of anti-infective medication approvals. Regulatory bodies' rapid approval of new pharmaceuticals ensures that patients have faster access to novel therapies. The constant development of novel medications, supported by clinical trials and improvements in medical science, boosts market expansion, providing healthcare professionals with a greater selection of therapeutic alternatives to effectively tackle infectious diseases.
• Due to the wide penetration of these treatments across multiple healthcare settings, the market for anti-infective agents provides enormous opportunities. With the prevalence of infectious diseases on the rise, the need for anti-infective drugs is constantly high. Increased access to healthcare facilities, increased awareness of infectious illness management, and the availability of generic versions all help to increase drug distribution.
• Extensive R&D activities give appealing perspective in the market for anti-infective drugs. Significant investment in R&D is driven by the ongoing search for innovative medications that tackle emerging diseases, antibiotic resistance, and unmet medical needs. Biotechnology, genomics, and drug delivery system advancements can lead to the development of more effective and targeted anti-infective treatments, broadening the market's potential customers.
• However, the high cost of anti-infective medications is a major commercial constraint. Expensive pharmaceuticals may restrict access to treatment for particular patient populations, causing economic concerns and impeding general adoption. This limitation may impact healthcare outcomes, particularly in areas with limited resources or inadequate healthcare coverage.
• Anti-infective agents have a substantial market challenge due to inadequate reimbursement rules. Inadequate coverage or low reimbursement rates provided by insurance companies and government healthcare programs may discourage healthcare practitioners from prescribing specific medications, resulting in limited patient access and substantial financial constraints for patients seeking treatment.

Market Segmentations

• The Global Anti-Infective Agents Market is segmented based on Type, Drug Class, Route of Administration, and Geography.
• By Type, the market is classified into Antibacterial, Antivirals, and Antifungals.
• Antibacterial holds a larger market share. Antibiotics are the most widely prescribed anti-infective medications due to the extensive occurrence of bacterial illnesses.
• By Drug Class, the market is classified into Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, and Carbapenem.
• Fluoroquinolones hold a significant market share. Their broad spectrum of activity, adaptability, and efficiency against many bacterial diseases contributed to their popularity and dominance in the market.
• By Route of Administration, the market is classified into Topical and Oral.
• Oral route of administration holds a larger market share. due to their convenience, ease of administration, and greater use for a variety of systemic and localized illnesses.
• By Geography, the market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.
• The Americas hold a significant market share. This was due to factors such as a higher prevalence of infectious diseases, well-established healthcare infrastructure, increased healthcare spending, and active R&D activities, contributing to the region's demand for and acceptance of anti-infective medications.

Recent Development

• GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health - April 2023
• Sun Pharma completes acquisition of Concert Pharmaceuticals - March 2023

Company Profiles

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Anti-Infective Agents Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The publisher analyses the Global Anti-Infective Agents Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Anti-Infective Agents Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The research report also provides a detailed Market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
• Excel data sheet for the market size will also be provided with the report.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
• The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
• Market segmentation
• Competitive Analysis: Comparative analysis of competitor
• Historical, current, and projected size of the market based on value and volume
• Market size of the US states
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market